Levemir



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 20.9%
Type 2 Diabetes Mellitus 16.8%
Type 1 Diabetes Mellitus 13.3%
Insulin-requiring Type Ii Diabetes Mellitus 12.1%
Insulin-requiring Type 2 Diabetes Mellitus 9.1%
Product Used For Unknown Indication 7.4%
Drug Use For Unknown Indication 6.8%
Diabetes Mellitus Insulin-dependent 5.8%
Hypertension 2.9%
Gestational Diabetes 0.9%
Drug Exposure During Pregnancy 0.7%
Blood Cholesterol Increased 0.6%
Prophylaxis 0.5%
Cardiac Failure 0.4%
Insomnia 0.4%
Diabetes Mellitus Non-insulin-dependent 0.3%
Hypothyroidism 0.3%
Blood Pressure 0.3%
Gastrooesophageal Reflux Disease 0.3%
Angina Pectoris 0.2%
Blood Glucose Increased 46.8%
Hypoglycaemia 4.7%
Blood Glucose Decreased 4.0%
Blood Glucose Fluctuation 3.9%
Injection Site Haemorrhage 3.7%
Injection Site Pain 3.7%
Injection Site Swelling 3.1%
Death 2.8%
Injection Site Pruritus 2.7%
Weight Increased 2.6%
Injection Site Rash 2.6%
Rash 2.6%
Vomiting 2.4%
Injection Site Erythema 2.3%
Injection Site Mass 2.3%
Urticaria 2.1%
Injection Site Bruising 2.0%
Injection Site Haematoma 1.9%
Injection Site Reaction 1.9%
Premature Baby 1.9%
Secondary
Type 2 Diabetes Mellitus 24.6%
Type 1 Diabetes Mellitus 17.1%
Product Used For Unknown Indication 13.2%
Diabetes Mellitus 12.0%
Drug Use For Unknown Indication 9.1%
Insulin-requiring Type 2 Diabetes Mellitus 6.7%
Hypertension 4.0%
Insulin-requiring Type Ii Diabetes Mellitus 3.5%
Diabetes Mellitus Insulin-dependent 2.7%
Blood Cholesterol Increased 1.1%
Gestational Hypertension 0.8%
Diabetes Mellitus Inadequate Control 0.7%
Sinusitis 0.7%
Diabetes Mellitus Non-insulin-dependent 0.6%
Drug Exposure During Pregnancy 0.6%
Hypothyroidism 0.6%
Depression 0.6%
Gestational Diabetes 0.5%
Anaemia Of Pregnancy 0.5%
Cardiac Failure 0.5%
Blood Glucose Increased 20.1%
Loss Of Consciousness 10.6%
Vomiting 7.9%
Hypoglycaemia 7.4%
Premature Baby 5.8%
Weight Decreased 5.0%
Weight Increased 4.5%
Blood Glucose Decreased 4.2%
Wrong Drug Administered 4.0%
Nausea 3.4%
Hypoglycaemic Unconsciousness 3.2%
Oedema Peripheral 3.2%
Microalbuminuria 2.9%
Rash 2.9%
Hypoglycaemic Seizure 2.6%
Large For Dates Baby 2.6%
Urinary Bladder Haemorrhage 2.6%
Blood Glucose Fluctuation 2.4%
Drug Exposure During Pregnancy 2.4%
Pneumonia 2.4%
Concomitant
Product Used For Unknown Indication 32.2%
Diabetes Mellitus 17.9%
Type 2 Diabetes Mellitus 12.0%
Hypertension 9.9%
Drug Use For Unknown Indication 6.2%
Type 1 Diabetes Mellitus 3.0%
Pain 3.0%
Prophylaxis 2.3%
Rheumatoid Arthritis 1.5%
Depression 1.4%
Hepatitis C 1.3%
Insulin-requiring Type 2 Diabetes Mellitus 1.2%
Gastrooesophageal Reflux Disease 1.2%
Hyperlipidaemia 1.1%
Atrial Fibrillation 1.0%
Asthma 1.0%
Psoriasis 0.9%
Blood Cholesterol Increased 0.9%
Multiple Myeloma 0.9%
Hypothyroidism 0.9%
Weight Decreased 15.7%
Vomiting 11.9%
Blood Glucose Increased 6.8%
Weight Increased 6.1%
Pancreatitis 5.9%
Renal Failure Acute 5.8%
Nausea 5.7%
Off Label Use 4.7%
Hypoglycaemia 4.3%
Pneumonia 4.1%
Death 3.6%
Myocardial Infarction 3.5%
Pain In Extremity 3.5%
Drug Ineffective 3.1%
Renal Failure 3.0%
Urinary Tract Infection 2.8%
Pain 2.4%
Visual Impairment 2.4%
Pancreatitis Acute 2.3%
Sepsis 2.3%
Interacting
Product Used For Unknown Indication 22.6%
Type 1 Diabetes Mellitus 9.7%
Type 2 Diabetes Mellitus 9.7%
Blood Cholesterol Increased 6.5%
Diabetes 6.5%
Diabetes Mellitus 6.5%
Sinusitis 6.5%
Attention Deficit/hyperactivity Disorder 3.2%
Bronchitis 3.2%
Gastric Disorder 3.2%
Hypertension 3.2%
Peripheral Arterial Occlusive Disease 3.2%
Restlessness 3.2%
Thyroid Disorder 3.2%
Acute Sinusitis 1.6%
Back Pain 1.6%
Blood Pressure High 1.6%
Ear Infection 1.6%
Hypercholesterolaemia 1.6%
Ischaemic Heart Disease Prophylaxis 1.6%
Hypoglycaemia 31.3%
Gastric Disorder 12.5%
Therapy Change 12.5%
Tremor 12.5%
Fatigue 6.3%
Loss Of Consciousness 6.3%
Muscle Spasticity 6.3%
Pruritus 6.3%
Therapeutic Response Decreased 6.3%